2nd Quarter - Report

MEHLMAN CONSULTING, INC. for MAYO CLINIC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General healthcare. General health reform implementation. Healthcare value and quality. ICD-10 implementation. Health information technology, clinical trials, telehealth. Precision medicine, delivery system reform. H.R. 6, 21st Century Cures Act.

LobbyistCovered position, as disclosed
LAUREN ARONSON New Professional Staff Member, Committee on Ways & Means; Policy Director, White House; Policy Director, HHS Office of Health Reform (detailed to the White House); Policy Advisor, Rep. Rahm Emanuel; Health LA, Rep. Carolyn McCarthy
KELLY RUCKER BINGEL —
DAVID CASTAGNETTI —
SAGE EASTMAN —
ELISE FINLEY PICKERING —
SOHINI GUPTA —
BRUCE MEHLMAN —
DEAN ROSEN —
DAVID R THOMAS —
CHARLES WOOTERS —
SUSAN ZOOK —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); Executive Office of the President (EOP); SENATE

Bills named: H.R. 6 (114th)

Medicare/Medicaid MMM

Quality payments for providers. Accountable care organizations. Clinical laboratory reimbursement. Physician payment policies.

Contacted: Office of Science & Technology Policy (OSTP); SENATE; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

NIH appropriations. Clinical laboratory reimbursement.

Contacted: Office of Science & Technology Policy (OSTP); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.